Description
A Unique Patented Technology (US Patent Number 11.040.081) Thanks to Genacols exclusive patented enzymatic hydrolysis technology, the AminoLock Sequence Technology, we obtain ultra-hydrolyzed collagen from a bovine source with the lowest molecular weight in the world, at less than 1 kilodalton (kDa). This exclusive Genacol technology used to help maintain healthy joints and cartilage is patented. A collaborative research project with the School of Human Nutrition at McGill University in Montreal, Canada made it possible to identify, quantify, and compare the bioavailability of key peptides after the process of digestion, absorption, and metabolization between Genacol collagen and a generic hydrolyzed collagen supplement. Results show that compared to generic collagen, Genacol exclusive enzymatic hydrolysis technology offers greater bioavailability, better absorption, and better metabolization. AminoLock Collagen is manufactured using Genacols proprietary manufacturing process: the AminoLock Sequence Technology. Developed by Genacols Research and Development division, this patented technology focuses on the amino acids that are the building blocks of collagen. Through improved enzymatic hydrolysis, we made it possible to obtain collagen at less than 1 kilodalton (kDa), the lowest molecular weight ever achieved. This unique feature of the AminoLock Collagen ensures fast absorption. Genacol is great for joint mobility and maintaining overall joint health.
Features